<DOC>
	<DOC>NCT01287507</DOC>
	<brief_summary>The aim of the study is to evaluate whether oral administration of 200 mg/day lactoferrin (LF) to very low birth weight infants reduces late onset sepsis and necrotising enterocolitis and the effect of LF on regulatory T cells.</brief_summary>
	<brief_title>Lactoferrin Prophylaxis in VLBW and Regulator T-cells</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Enterocolitis</mesh_term>
	<mesh_term>Enterocolitis, Necrotizing</mesh_term>
	<mesh_term>Lactoferrin</mesh_term>
	<criteria>Inborn infants Gestational age &lt; 32 weeks Birth weight &lt; 1500 g Parental consent Congenital abnormalities Severe perinatal asphyxia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Day</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>VLBW, NEC, Late onset sepsis</keyword>
</DOC>